l General Information |
Product Name | Vorasidenib (AG-881) |
General description | Vorasidenib (AG-881) is an orally available inhibitor of mutated forms of both isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2). |
Synonym | 6-(6-chloropyridin-2-yl)-2-~{N},4-~{N}-bis[(2~{R})-1,1,1-trifluoropropan-2-yl]-1,3,5-triazine-2,4-diamine |
Purity | ≥98.5%(HPLC) | CAS Number | 1644545-52-7 |
Formula | C14H13ClF6N6 | Molecular Weight | 414.74 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | Solid |
Solubility(25°C) | DMSO | ≥50mg/mL |
Ethanol | ≥50mg/mL |
Water | Very slightly soluble |
l Storage |
Storage temp. | -20°C |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
